Skip to content

Validation Study on RENEW's Aingeal at KK Women's and Children's Hospital

Validation Study on RENEW's Aingeal at KK Women's and Children's Hospital

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03754231
Enrollment
10
Registered
2018-11-27
Start date
2018-01-30
Completion date
2021-12-01
Last updated
2022-03-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vital Sign, Heart Rate, Respiratory Rate

Keywords

Vital sign monitoring, Heart rate, Respiratory rate

Brief summary

This proposal describes the evaluation of a CE-marked, FDA cleared vital signs Surveillance Monitoring system in a paediatric outpatient population in KK Women's and Children's Hospital (KKH), the main tertiary women and children hospital in Singapore. User acceptance of Aingeal and the Surveillance System will be considered within the clinical settings.

Detailed description

RENEW's Surveillance Monitoring system is made up of two main components: a patient-worn wireless vital signs monitor (Aingeal) that transmits data over Wi-Fi to a central station software platform (Surveillance Station). The Aingeal device measures single lead ECG, heart rate, respiration waveform and rate, and skin temperature. A snapshot of data is transmitted by the devices intermittently to the Surveillance Station, enabling vital signs trends to be plotted. This proposal describes the evaluation of RENEW's Aingeal device in a paediatric outpatient population in KK Women's and Children's Hospital (KKH), the main tertiary women and children hospital in Singapore. In the paediatric population, assessment of RENEW's Aingeal device will include the accuracy of the device at deriving heart rate from single lead ECG and at deriving respiratory rate when compared against a commonly used vital signs monitor. User acceptance of Aingeal and the Surveillance System will be considered within the clinical settings.

Interventions

The heart rate of recruited patients will be monitored for 15 minutes over 2 phases: i) 10 minutes at rest ii) 5 minutes during physical activity in the form of walking or playing

OTHERRespiratory rate monitoring

The heart rate of recruited patients will be monitored for 15 minutes over 2 phases: i) 10 minutes at rest ii) 5 minutes during physical activity in the form of walking or playing

Sponsors

Renew Group
CollaboratorINDUSTRY
KK Women's and Children's Hospital
Lead SponsorOTHER_GOV

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Intervention model description

All patients recruited will be wearing the Aingeal device at a paediatric outpatient clinic setting.

Eligibility

Sex/Gender
ALL
Age
3 Years to 17 Years
Healthy volunteers
No

Inclusion criteria

* Male or female paediatric patients, aged between 3 and 17 years * Patients attending outpatient care at KK Women's and Children's Hospital, Singapore

Exclusion criteria

* Patients with active, implantable devices (such as a pacemaker or ICD) * Patients with any skin condition or injury affecting the electrode placement site * Patients that are pregnant * Those patients who, in the opinion of the clinic staff, are not suitable to participate.

Design outcomes

Primary

MeasureTime frameDescription
Heart rate comparison15 minutesHeart rate is calculated manually via ECG waveform and compared against the Aingeal device using Bland Altman approach

Secondary

MeasureTime frameDescription
Respiratory rate comparison15 minutesRepiratory rate measurement is compared between Aingeal device and Capnostream device using Bland Altman approach.

Countries

Singapore

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026